These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 10980893)

  • 1. Natriuretic peptides in the pathophysiology of congestive heart failure.
    Chen HH; Burnett JC
    Curr Cardiol Rep; 2000 May; 2(3):198-205. PubMed ID: 10980893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain natriuretic peptide: role in cardiovascular and volume homeostasis.
    Dhingra H; Roongsritong C; Kurtzman NA
    Semin Nephrol; 2002 Sep; 22(5):423-37. PubMed ID: 12224050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The natriuretic peptides in heart failure: diagnostic and therapeutic potentials.
    Chen HH; Burnett JC
    Proc Assoc Am Physicians; 1999; 111(5):406-16. PubMed ID: 10519161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natriuretic peptides and their therapeutic potential.
    Cho Y; Somer BG; Amatya A
    Heart Dis; 1999; 1(5):305-28. PubMed ID: 11720638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Functional compartmentation of the endocrine action of cardiac natriuretic peptides].
    Haloui M; Arnal JF; Pham I; Gonzalez W; Lyoussi B; Michel JB
    Ann Endocrinol (Paris); 2000 Feb; 61(1):32-40. PubMed ID: 10790590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Natriuretic peptides--their receptors and role in cardiovascular system].
    Jerczyńska H; Pawłowska Z
    Postepy Biochem; 2008; 54(1):35-42. PubMed ID: 18610580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
    Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
    Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of dendroaspis natriuretic peptide and its binding to NPR-A receptor in rabbit kidney.
    Kim SM; Kim YA; Kim SY; Kim SH; Cho KW; Kim SZ
    Regul Pept; 2011 Feb; 167(1):42-9. PubMed ID: 21130122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natriuretic peptides BNP and CNP increase heart rate and electrical conduction by stimulating ionic currents in the sinoatrial node and atrial myocardium following activation of guanylyl cyclase-linked natriuretic peptide receptors.
    Springer J; Azer J; Hua R; Robbins C; Adamczyk A; McBoyle S; Bissell MB; Rose RA
    J Mol Cell Cardiol; 2012 May; 52(5):1122-34. PubMed ID: 22326431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of natriuretic peptides and their interrelation with endothelin-1.
    Han B; Hasin Y
    Cardiovasc Drugs Ther; 2003 Jan; 17(1):41-52. PubMed ID: 12843686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The renal and cardiovascular effects of natriuretic peptides.
    Wong PC; Guo J; Zhang A
    Adv Physiol Educ; 2017 Jun; 41(2):179-185. PubMed ID: 28377431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Equimolar doses of atrial and brain natriuretic peptides and urodilatin have differential renal actions in overt experimental heart failure.
    Chen HH; Cataliotti A; Schirger JA; Martin FL; Burnett JC
    Am J Physiol Regul Integr Comp Physiol; 2005 May; 288(5):R1093-7. PubMed ID: 15627648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natriuretic peptides and therapeutic applications.
    Lee CY; Burnett JC
    Heart Fail Rev; 2007 Jun; 12(2):131-42. PubMed ID: 17440808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of membrane guanylyl cyclases in congestive heart failure: natriuretic peptide receptor (NPR)-B, Not NPR-A, is the predominant natriuretic peptide receptor in the failing heart.
    Dickey DM; Flora DR; Bryan PM; Xu X; Chen Y; Potter LR
    Endocrinology; 2007 Jul; 148(7):3518-22. PubMed ID: 17412809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-type natriuretic peptide: the endothelial component of the natriuretic peptide system.
    Chen HH; Burnett JC
    J Cardiovasc Pharmacol; 1998; 32 Suppl 3():S22-8. PubMed ID: 9883743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism.
    Borgeson DD; Stevens TL; Heublein DM; Matsuda Y; Burnett JC
    Clin Sci (Lond); 1998 Aug; 95(2):195-202. PubMed ID: 9680502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in natriuretic peptides in congestive heart failure.
    Boerrigter G; Burnett JC
    Expert Opin Investig Drugs; 2004 Jun; 13(6):643-52. PubMed ID: 15174950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of a natriuretic peptide family and their clinical application.
    Matsuo H
    Can J Physiol Pharmacol; 2001 Aug; 79(8):736-40. PubMed ID: 11558683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic actions of a new synthetic vasoactive and natriuretic peptide, dendroaspis natriuretic peptide, in experimental severe congestive heart failure.
    Lisy O; Lainchbury JG; Leskinen H; Burnett JC
    Hypertension; 2001 Apr; 37(4):1089-94. PubMed ID: 11304508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of natriuretic peptides upon hypothalamo-pituitary-adrenocortical system activity and anxiety behaviour.
    Wiedemann K; Jahn H; Kellner M
    Exp Clin Endocrinol Diabetes; 2000; 108(1):5-13. PubMed ID: 10768826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.